Citation: | ZHAIYi, PANXiao-ye, WUHao-xin. The Improvement of Atherosclerosis from Zexieyin by Regulating Cholesterol Metabolism in the Apolipoprotein E-Deficient Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(4): 472-477. |
[1] |
LIBBY P, BURING JE, BADIMON L, et al. Atherosclerosis[J]. Nat Rev Dis Primers, 2019,5(1):56.
|
[2] |
CHISTIAKOV DA,MELNICHENKO AA,MYASOEDOVA VA,et al.Mechanisms of foam cell formation in atherosclerosis[J].J Mol Med,2017,95(11):1153-1165.
|
[3] |
CLARK D,VIRANI SS.2018 cholesterol guidelines:Key topics in primary prevention[J].Curr Atheroscler Rep,2019,21(5):17.
|
[4] |
王亚兰, 卢汉祺, 杨满妹, 等. “泽泻饮”古今临床运用[J]. 光明中医, 2014,29(11):2259-2260.
|
[5] |
倪士峰, 巩江, 安亚文, 等. 内经十三方研究概况[J]. 陕西中医学院学报, 2009,32(3):72-74.
|
[6] |
王磊.泽泻饮合京三棱丸治疗非酒精性脂肪肝34例[J].西部中医药,2013,26(9):64-65.
|
[7] |
XUE X, CHEN T, WEI W, et al. Effects of Alisma Decoction on lipid metabolism and inflammatory response are mediated through the activation of the LXRalpha pathway in macrophage-derived foam cells[J]. Int J Mol Med, 2014,33(4):971-977.
|
[8] |
唐雪梅, 翟玉祥, 刘涛, 等. 加味泽泻饮对实验性高脂血症大鼠血液流变学及血清一氧化氮的影响[J]. 中国实验方剂学杂志, 2006,12(5):26-28.
|
[9] |
BRIEL M,FERREIRA-GONZALEZ I,YOU JJ,et al.Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality:Systematic review and meta-regression analysis[J].BMJ,2009,338:b92.
|
[10] |
LEWINGTON S,WHITLOCK G,CLARKE R, et al.Blood cholesterol and vascular mortality by age,sex,and blood pressure:A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths[J].Lancet,2007,370(9602):1829-1839.
|
[11] |
MONETA GL.Cholesterol efflux capacity,high-density lipoprotein function,and atherosclerosis[J].Yearb Vasc Surg,2011,2011:6-8.
|
[12] |
GRAF GA,YU LQ,LI WP,et al.ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion[J].J Biol Chem,2003,278(48):48275-48282.
|
[13] |
BROWN JM,YU LQ.Protein mediators of sterol transport across intestinal brush border membrane[J].Subcell Biochem,2010,51:337-380.
|
[14] |
ROBICHON C,DUGAIL I.De novo cholesterol synthesis at the crossroads of adaptive response to extracellular stress through SREBP[J].Biochimie,2007,89(2):260-264.
|
[15] |
WANG LJ,SONG BL.Niemann-Pick C1-Like 1 and cholesterol uptake[J].Biochim Biophys Acta,2012,1821(7):964-972.
|
[16] |
VAN DER VEEN JN,VAN DIJK TH,VRINS CL,et al.Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol[J].J Biol Chem,2009,284(29):19211-19219.
|
[17] |
REPA JJ,BERGE KE,POMAJZL C,et al.Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and Β[J].J Biol Chem,2002,277(21):18793-18800.
|
[18] |
YASUDA T,GRILLOT D,BILLHEIMER JT,et al.Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo[J].Arterioscler Thromb Vasc Biol,2010,30(4):781-786.
|
[19] |
RUSSELL DW,SETCHELL KDR.Bile acid biosynthesis[J].Biochemistry,1992,31(20):4737-4749.
|
[20] |
ALBERTI S,SCHUSTER G,PARINI P,et al.Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice[J].J Clin Invest,2001,107(5):565-573.
|
[21] |
LI WK,LI H,LU YF,et al.Atorvastatin alters the expression of genes related to bile acid metabolism and circadian clock in livers of mice[J].Peer J,2017,5:e3348.
|
[22] |
YU LQ,GUPTA S,XU F,et al.Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion[J].J Biol Chem,2005,280(10):8742-8747.
|
[23] |
PRAMFALK C,JIANG ZY,CAI Q,et al.HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver[J].J Lipid Res,2010,51(6):1354-1362.
|
[24] |
IWAYANAGI Y,TAKADA T,SUZUKI H.HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1[J].Pharm Res,2008,25(5):1134-1141.
|
[25] |
ALREFAI WA,ANNABA F,SARWAR Z,et al.Modulation of human Niemann-Pick C1-like 1 gene expression by sterol:Role of sterol regulatory element binding protein 2[J].Am J Physiol Gastrointest Liver Physiol,2007,292(1):369-376.
|